Bedside Swallowing Evaluation: A Nurse and Caregiver Guide to Recognising Dysphagia

The bedside swallowing evaluation (BSE) is typically the first structured assessment of swallowing function that a patient with suspected dysphagia receives. It is conducted by a nurse, occupational therapist, or trained caregiver — not initially by an SLT — and its primary purpose is screening: identifying patients at sufficient risk to warrant full SLT assessment, and preventing unsafe oral intake in the interim.

Understanding what a BSE can and cannot tell you is essential for safe clinical practice.

This article follows ASHA Practice Portal guidance on adult dysphagia and NICE CG162.


The Critical Limitation: BSE Cannot Detect Silent Aspiration

The single most important fact about bedside swallowing evaluation is its limited sensitivity for detecting aspiration — and near-zero sensitivity for detecting silent aspiration. Studies consistently show that clinical bedside evaluation without instrumentation has a sensitivity of 40–60% for identifying aspiration, compared with VFSS or FEES as the gold standard.

Silent aspiration — aspiration without coughing or throat-clearing — occurs in 40–50% of patients with neurogenic dysphagia and is not detectable by any non-instrumental method. A patient who passes a bedside water swallow test without coughing may still be aspirating silently.

This means BSE should be understood as a risk stratification tool, not a definitive safety clearance. The appropriate response to a failed BSE is urgent SLT referral. The appropriate response to a passed BSE in a high-risk patient (neurological diagnosis, recurrent chest infections) is also SLT referral for full assessment.


Pre-Screening: Before Any Swallow Trial

Before conducting any swallow trial, assess the following:

Level of Consciousness and Alertness

The patient must be sufficiently alert to participate safely — defined as able to maintain an upright position for 15 minutes and respond to basic verbal commands. Swallowing assessment in a drowsy or unconscious patient is not safe.

Postural Control

Can the patient be positioned at 90 degrees upright? Supine or severely reclined positions increase aspiration risk. If the patient cannot maintain an upright position, oral intake should be deferred.

Oral Hygiene Status

Note dental condition, saliva volume, and oral hygiene. Heavy plaque or poor oral hygiene is relevant to aspiration pneumonia risk even if swallowing function proves adequate.

Voice Quality at Baseline

Ask the patient to say “ah” or read a sentence. Note voice quality before any swallowing — hoarse, weak, or breathy voice at baseline suggests pre-existing vocal fold compromise.


The 3-oz (90 mL) Water Swallow Test / Water Swallow Protocols

Several validated bedside swallowing screening protocols use water as the test bolus:

Modified Water Swallow Test (Commonly Used in HK)

  1. Position the patient upright (90 degrees)
  2. Give 5 mL of water via teaspoon; observe for coughing, choking, or wet voice change
  3. If safe: give 10 mL, then 20 mL in a cup
  4. If no difficulties: give 50 mL to drink from a cup at the patient’s own pace

FAIL criteria: coughing during or within 1 minute of swallow, wet/gurgly voice change, distress, oxygen desaturation ≥2%.

3-oz Water Swallow Test (DePippo et al., 1992)

Used in some acute stroke wards. The patient drinks 90 mL of water in a single continuous trial. Failure is defined as coughing, voice change, or incomplete drinking. Sensitivity ~76% for detecting aspiration of thin liquids.

Limitation: Even with failure identified, the test does not reveal which IDDSI level is safe.


Clinical Indicators During Observation

During a meal or swallow trial, observe for:

SignClinical Meaning
Coughing during eating/drinkingPossible aspiration or penetration at time of swallow
Coughing 1–3 minutes after swallowingPossible post-swallow aspiration of residue
Wet/gurgly voice after swallowingPooling of material in the piriform sinuses or on the vocal folds
Throat clearing repeatedly during mealAwareness of residue; attempting to clear pharyngeal pooling
Multiple swallows per bolusPost-swallow residue requiring additional clearance swallows
Oral residue after swallowReduced tongue strength; oral phase failure
Anterior droolingReduced lip closure
Mealtime duration >30 minutesGeneralised swallowing inefficiency
Unexplained temperature or respiratory symptomsPossible silent aspiration event

Importantly, absence of coughing during observation does NOT confirm safe swallowing.


Validated Screening Tools

EAT-10 (Eating Assessment Tool-10)

A 10-item self-report questionnaire — the patient rates each item from 0 (no problem) to 4 (severe problem). Score ≥3 indicates dysphagia risk. Validated in multiple languages and populations. Available in Chinese (Traditional and Simplified) for use in Hong Kong. Takes approximately 2 minutes to complete.

GUSS (Gugging Swallowing Screen)

A four-part staged swallowing evaluation from saliva swallow → semisolid → liquid → solid, with yes/no observation criteria at each stage. Provides an IDDSI-compatible recommendation based on performance. Validated for acute stroke; increasingly used in other settings.

Toronto Bedside Swallowing Screening Test (TOR-BSST)

Validated for acute stroke populations; sensitivity 91.3% for dysphagia detection.


When BSE Results Indicate Referral

Any of the following warrant immediate SLT referral:

In Hong Kong, SLT referral within 24 hours is recommended for all acute stroke patients regardless of BSE result, consistent with NICE CG162. See When to Refer to a Speech and Language Therapist for full referral guidance.


References

  1. American Speech-Language-Hearing Association. Adult Dysphagia Practice Portal. https://www.asha.org/practice-portal/clinical-topics/adult-dysphagia/
  2. National Institute for Health and Care Excellence. Stroke Rehabilitation in Adults (CG162). https://www.nice.org.uk/guidance/cg162
  3. IDDSI. The IDDSI Framework. https://www.iddsi.org/framework
  4. Logemann JA, et al. (2015). Disorders of deglutition. Handbook of Clinical Neurology, 129, 465–487. PMID: 26315994